The stability of citrate-capped silver nanoparticles in isotonic glucose solution for intravenous injection

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 76, Issue 22, 2013, Pages 1236-1245

  Park, Kwangsik ^a   Lee, Yeonjin ^a  

^a Dongduk Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; GLUCOSE; ISOTONIC SOLUTION; SILVER NANOPARTICLE;

ARTICLE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; OSMOTIC PRESSURE; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; TOXICITY TESTING; TOXICOKINETICS; ZETA POTENTIAL;

CHEMICAL PRECIPITATION; CITRATES; DRUG STABILITY; GLUCOSE; ISOTONIC SOLUTIONS; METAL NANOPARTICLES; OSMOTIC PRESSURE; SILVER; TIME FACTORS;

EID: 84889565814     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2013.849215     Document Type: Article

References (29)

1. Ahamed, M., Karns, M., Goodson, M., Rowe, J., Hussain, S. M., Schlager, J. J., and Hong, Y. 2008. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cell. Toxicol. Appl. Pharmacol. 233: 404-410.
2. Arora, S., Jain, J., Rajwade, J. M., and Paknikar, K. M. 2009. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol. 236: 310-318.
3. AshaRani, P. V., Low KahMun, G., Hande, M. P., and Valiyaveettil, S. 2009. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-290.
4. Ávalos Fúnez, A., Isabel Haza, A., Mateo, D., and Morales, P. 2013. In vitro evaluation of silver nanoparticles on human tumoral and normal cells. Toxicol. Mech. Methods 23: 153-160.
5. Badawy, A. M., Scheckel, K. G., Suidan, M., and Tolaymat, T. 2012. The impact of stabilization mechanism on the aggregation kinetics of silver nanoparticles. Sci. Total Environ. 429: 325-331.
6. Braydich-Stolle,L., Hussain, S., Schlager, J. J.,and Hofmann, M. C. 2005. In vitro cytotoxicity of nanoparticles in mammalian germ line stem cells. Toxicol. Sci. 88: 412-419. (Pubitemid 41672149)
7. Carlson C., S. M. Hussain, A. M. Schrand, L. K. Braydich-Stolle, K. L. Hess, R. L. Jones, and J. J. Schlager. 2008. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 112 13608-13619.
8. Cunningham, S., Brennan-Fournet, M. E., Ledwith, D., Byrnes, L., and Joshi, L. 2013. Effect of nanoparticle stabilization and physicochemical properties on exposure outcome: acute toxicity of silver nanoparticle preparations in zebrafish (Danio rerio). Environ. Sci. Technol. 47: 3883-3892.
9. Donaldson, K., and Poland, C. A. 2013. Nanotoxicity: challenging the myth of nanospecific toxicity. Curr. Opin. Biotechnol. 24: 724-734.
10. Gagne, F., Auclair, J., Turcotte, P., and Gagnon, C. 2013a. Sublethal effects of silver nanoparticles in freshwater mussels. J. Toxicol Environ Health A 76: 479-490.
11. Gagne, F., Auclair, J., Fortier, M., Bruneau, A., Fournier, M., Turcotte, P., Pilote. M., and Gagnon, C. 2013b. Bioavailability and immunotoxicity of silver nanoparticles to the freshwater mussel Ellipto complanata. J. Toxicol. Environ Health A 76: 767-777.
12. Hadrup, N., K. Loeschner, A. Bergström, A. Wilcks, X. Gao, U. Vogel, H.L. Frandsen, E.H. Larsen, H.R. Lam, and Mortensen A. 2013. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch. Toxicol. 86: 543-551.
13. Hong, J. S., Kim, S., Lee, S. H., Jo, E., Lee, B., Yoon, J., Eom, I. C., Kim, H. M., Kim, P., Choi, K., Lee, M. Y., Seo, Y. R., Kim, Y., Lee, Y., Choi, J., and Park, K. 2013. Combined repeated-dose toxicity study of silver nanoparticles with the reproduction/developmental toxicity screening test. Nanotoxicology Early online 1-14. DOI: 10.3109/17435390.2013.780108
14. Hsin, Y. H., Chen, C. F., Huang, S., Shih, T. S., Lai, P. S., and Chueh, P. J. 2008. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 179: 130-139.
15. Huls, N. F., Phan, M. H., Kumar, A., Mohapatra, S., Mukherjee, P., and Srikanth, H. 2013. Transverse susceptibility as a biosensor for detection of Au-Fe3O4 nanoparticleembedded human embryonic kidney cells. Sensors (Basel). 13: 8490-8500.
16. Huynh, K. A., and Chen, K. L. 2011. Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions. Environ. Sci. Technol. 45: 5564-5571.
17. Kim, J. S., Song, K. S., Sung, J. H., Ryu, H. R., Choi, B. G., Cho, H. S., Lee, J. K., and Yu, I. J. 2013. Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitization evaluation of silver nanoparticles. Nanotoxicology 7: 953-960
18. Kim, W. Y., Kim, J., Park, J. D., Ryu, H. Y., and Yu, I. Y. 2009. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J Toxicol Environ Health A 72: 1279-1284.
19. Kim, Y. S., Kim, J. S., Cho, H. S., Rha, D. S., Kim, J. M., Park, J. D., Choi, B. S., Lim, R., Chang, H. K., Chung, Y. H., Kwon, I. H., Jeong, J., Han, B. S., and Yu, I. J. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583. (Pubitemid 351601408)
20. Liu, J., and Hurt, R. H. 2010. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ. Sci. Technol. 44: 2169-2175.
21. Mishra, D., Hubenak, J. R., and Mathur, A. B. 2013. Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. J. Biomed. Mater. Res. A doi:10.1002/jbm.a.34642 (Epub ahead of print).
22. Munger, M. A., Radwanski, P., Hadlock, G. C., Stoddard, G., Shaaban, A., Falconer, J., Grainger, D. W., and Deering-Rice, C. E. 2013. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine. doi:10.1016/j.nano.2013.06.010 (Epub ahead of print).
23. Park, E. J., Yi, J., Kim, Y., Choi, K., and Park, K. 2010. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol. In Vitro 24: 872-878.
24. Park, E., Bae, E., Yi, J., Kim, Y., Choi, K., Lee, S. H., Yoon, J., Lee, B. C., and Park, K. 2010. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 30: 162-168.
25. Park, K., Park, H. J., Chun, I., Choi, K., Lee, S. H., Yoon, J., and Lee, B. C. 2011. Bioavailability and toxicokinetics of citratecoated silver nanoparticles in rats. Arch. Pharm. Res. 34: 153-158.
26. Park, K., Tuttle, G., Sinche, F., and Harper, S. L. 2013. Stability of citrate-capped silver nanoparticles in exposure media and their effects on the development of embryonic zebrafish (Danio rerio). Arch. Pharm. Res. 36: 125-133.
27. Wang, A. Z., Langer, R., and Farokhzad, O. C. 2012. Nanoparticle delivery of cancer drugs. Ann. Rev. Med. 63: 185-198.
28. You, C., Han, C., Wang, X., Zheng, Y., Li, Q., Hu, X., and Sun, H. 2012. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol. Biol. Rep. 39: 9193-9201.
29. Zhao, J., and Castranova, V. 2011. Toxicology of nanomaterals use in medicine. J Toxicol Environ Health B 14: 593-632.